INTRODUCTION
Sandhoff disease (SD) and Tay-Sachs disease (TSD) (the main forms of GM2 gangliosidosis) are rare neurodegenerative lysosomal storage disease (LSD) caused by mutations in the HEXB and HEXA genes, respectively, encoding for the βand subunit of the -Hexosaminidase enzyme (E.C.3.2.1.52; β-Hex) [1] .
HexA, an αβ heterodimer, and HexB, a ββ homodimer, are the two major forms of β-Hex [2] , while HexS (αα) is a minor form with negligible catalytic activity [3, 4] . The lysosomal accumulation of GM2 ganglioside and related glycolipids consequent to β-Hex deficiency is ubiquitous but particularly abundant in CNS tissues and neurons, which undergo severe and progressive dysfunction and death [5] [6] [7] . In the most severe (infantile) forms of SD and TSD clinical decline is rapid and death occurs a few years after the diagnosis [8] .
There are currently no treatments for GM2 gangliosidosis. The infusion of the recombinant enzyme [9- J o u r n a l P r e -p r o o f 5 quantification of cells immunoreactive for the different antigens showed similar proportions of neurons (TUJ1), astrocytes (GFAP), and oligodendrocytes (O4) in both UT and LV-transduced NPC-derived progeny (differentiated cells, obtained by culturing NPCs in FGF2 for 2 days and then in a mitogen-free medium supplemented with 2% FBS for additional 5 days) ( Fig.1E-F ).
Overall these data show that transduction using mono-and bicistronic LVs is well tolerated by NPCs and does not impact on their functional features.
Stable expression of the α-and β-subunits, supranormal -Hex activity, and correct isoenzyme composition mediated by bicistronic LVs in SD NPCs and progeny.
We assessed the efficacy of bicistronic LVs in achieving optimal expression of the α-and β-subunit, correct isoenzyme composition, and restoration of β-Hex activity. To this end, we measured the mRNA expression of murine and human Hex genes, β-Hex activity and isoforms in two NPC-derived types of cultures (UT and LV-transduced): i) a cell population enriched in proliferating and undifferentiated cells, obtained by culturing NPCs for two days in EGF+FGF2 (precursor cells); (ii) NPC-derived mixed neuronal/glial cultures (differentiated cells; see Fig.1E -F).
We assessed mRNA expression by qPCR exploiting probes recognizing the native or the codonoptimized sequences of the Hex genes. The probes toward the native sequence allowed us determining: i) the endogenous (physiological) Hexa and Hexb mRNA in untreated (UT) WT and SD cells; ii) the total level of Hexa and Hexb mRNA (endogenous + transgenic) in NPCs transduced with monocistronic vectors, whose sequence is not codon-optimized (LV.mA, LV.mB); iii) the endogenous mRNA in NPCs transduced with bicistronic vectors (LV.mAB, LV.hAB). The probes toward the codon-optimized sequences do not recognize the native sequences, thus detecting only the transgenic mRNA in cells transduced with bicistronic vectors.
UT SD precursors ( Fig.2A ) and differentiated cells ( Fig.2B ) showed normal pattern of endogenousHexa and strongly reduced levels of endogenous Hexb mRNA expression as compared to the WT counterpart.
LV.mB-transduced SD cells displayed a significant upregulation of total Hexb mRNA expression (≈100and ≈20-fold the WT levels in precursors and differentiated cells, respectively; mainly reflecting the transgene overexpression given the low endogenous levels), without changes in the endogenous Hexa mRNA expression. The co-delivery of monocistronic LVs (LV.mA+LV.mB) in SD cells resulted in upregulation of both genes, with a 10-fold higher expression of total Hexb as compared to total Hexa mRNA expression ( Fig.2A-B ). The expression of transgenic Hexb and Hexa mRNAs (codon optimized sequence) was high and comparable in SD cells transduced with the bicistronic LV.mAB (up to 30-fold the normal levels), while a J o u r n a l P r e -p r o o f 6 therefore by HexA (αβ), HexB (ββ), and HexS (αα); MUGS is hydrolysed only by the α subunit, and therefore by HexA and HexS. UT SD cells show barely detectable levels of MUG-and MUGS-related enzymatic activity ( Fig.2C, precursors; Fig.2D , differentiated cells). Transduction of SD cells with LV.mB was sufficient to achieve supraphysiological level of enzymatic activity (8-and 5-fold the WT levels for precursors and differentiated cells with MUG, respectively) ( Fig.2C-D) . Transduction with LV.mB + LV.mA and bicistronic LVs ensured supraphysiological enzymatic activity (≈10 -40-fold the WT levels). Of note, we detected +30% and +100% of MUG and MUGS-related activity, respectively, in SD cells transduced with bicistronic LVs as compared to those transduced with LV.mA+LV.mB, resulting in close to physiological MUG/MUGS ratio (≈2 and ≈4 in WT precursors and differentiated cells, respectively) ( Fig.2C-D) . Importantly, the supraphysiological enzymatic activity was achieved using half the vector dose with bicistronic LVs. The pattern of enzymatic reconstitution upon transduction with different LVs was stable along NPC differentiation towards neurons and glia (Suppl. Fig. 1A-B ).
The chromatographic analysis corroborated the evidence of LV-mediated β-Hex rescue/overexpression and, in combination with the enzymatic assay through MUG and MUGS substrates, provided additional information about the subunit composition of Hex isoenzymes [39, 42, 43] . In our experimental conditions HexB was eluted with the void volume from the column, whereas HexA, HexS, and intermediate forms were retained by the column and eluted with a linear gradient of NaCl (0.0-0.5M) based on their respective isoelectric points. The chromatographic profile of WT UT NPCs ( Fig. 2E) showed two peaks of activity corresponding to HexB (43% of total Hex activity) and HexA (57% of total Hex activity) (Suppl. Table 1 ).
The isoenzyme ratio changed in differentiated cells, in which HexA accounted for ≈90% of total Hex activity (Suppl. Fig.1C ; Suppl. Table 1 ). In SD precusors ( Fig.2F ) and differentiated cells (Suppl. Fig.1D ) the residual activity eluted with the high concentration of NaCl might correspond to HexS, due to the absence of the -subunit. Transduction of SD NPCs with LV.mB caused the formation of HexB (11% of total Hex activity), HexA (36% of total Hex activity), and an additional consistent peak of activity (53 % of total Hex activity) eluted at a lower NaCl concentration with respect to HexA and detectable only with the MUG substrate ( Fig.2G ; Suppl. Table 1 ). This form might correspond to a Hex intermediate form composed of  precursors that we have documented in murine brain tissues during development and in NPCs and that we named HexI [39] . In SD NPCs transduced with LV.hexa+LV.hexb the overexpression of both andsubunits generated the formation of HexB (6% of total Hex activity), HexA (53% of total Hex activity), HexI (22% of total Hex activity), and HexS (9% of total Hex activity) ( Fig.2H ; Suppl. Table 1 ).
The transduction of SD NPCs with bicistronic LV.mAB generated a high amount of HexA (67% of total Hex activity) but little HexB (3% of total Hex activity) and a consistent HexI (30% of total Hex activity) J o u r n a l P r e -p r o o f LV.hAB-transduced cells showed mature expression of the HexA and HexB proteins [29, 30, 44, 45] (Suppl.
Fig.1G).
Overall these data strongly suggest that bicistronic LVs drive a stoichiometric expression of and subunits that is not fully guaranteed by the co-delivery of monocistronic LVs and ensure a close to physiological reconstitution of isoenzyme composition coupled to supraphysiological levels of functional HexA and HexB.
Rescue of β-Hex activity and metabolic correction in LV-transduced and cross-corrected NPC-derived neurons and glial cells
Qualitative and quantitative IF analysis showed the expansion of the lysosomal compartment (LAMP1) and accumulation of GM2 ganglioside in SD NPC-derived progeny as compared to WT counterparts These results confirm NPC cultures as a valuable model recapitulating the GM2 storage and lysosomal abnormalities that characterize SD pathology. In addition, they suggest that the functional HexA enzyme generated by the simultaneous delivery of and -subunits is sufficient to rescue the primary biochemical and functional disease hallmarks in this in vitro culture system.
The therapeutic efficacy of gene therapy strategies greatly relies on the capability of genetically modified cells to secrete part of functional lysosomal enzyme for its uptake by neighbouring enzyme-deficient cells (metabolic cross-correction). In order to check the occurrence of cross-correction in our system, we exposed SD NPCs and progeny (acceptor cells) to the supernatant of WT UT or LV.mAB-transduced SD cells (donor cells) during the differentiation process (Suppl. Fig.2A) . At the end of the experiment, we analyzed β-Hex activity and GM2 storage in SD cross-corrected neuronal/glial progeny. Supraphysiological enzymatic activity in LV.mAB-transduced SD NPCs (15-fold the normal) correlated to higher enzymatic activity in the supernatant ( Fig.4A-B and Suppl. Fig.2B ). The presence of supranormal vs. physiological levels of β-Hex activity in the supernatant moderately enhanced cross-correction, as shown by the 2-fold higher intracellular MUG-related enzymatic activity measured in SD cross-corrected cells (Fig.4C) , to reach up to 20% of WT activity. Of note, DEAE-cellulose chromatography showed the presence of HexB, HexI and HexA in all cross-corrected SD cells, with an improved rescue of enzymatic activity in SD cells exposed to the supernatant from LV.mAB-transduced SD cells as compared to WT UT cells, further confirming that enzyme overexpression enhances metabolic cross-correction of SD cells (Fig.4D ). The 30-40% reduction of J o u r n a l P r e -p r o o f chromatography (TLC) and quantification of radioactive bands showed a modest (<10%) reduction in the content of GM2 but a much stronger reduction (30-60%) in the content of its asialo form GA2 in crosscorrected cells as compared to SD UT cells, with a clear advantage observed in the presence of enzymeenriched supernatant ( Fig.4G -H). The discrepancy in GM2 reduction observed by TLC as compared to immunofluorescence with the anti-GM2 antibody ( Fig.4E ) may reflect the peculiarities and intrinsic limitations of these very different assays in capturing the complex ganglioside metabolism occurring in neural cell types.
Collectively, these data support the occurrence of GM2 clearance by supernatants from WT and transduced cells (with an advantage of the latter), indicating that the functional transgenic enzyme is secreted, recaptured by SD cells, and correctly delivered to lysosomes.
Efficient transduction and enzymatic rescue of murine HSPCs by bicistronic LVs
The optimization of gene transfer protocols ensuring the production and secretion of (supra) physiological HexA levels from HSPCs and progeny is mandatory to exploit the potential of autologous HSC GT approaches for GM2 gangliosidosis. To this end, we tested the efficacy of bicistronic LVs in achieving safe β-Hex rescue/overexpression in lineage negative (Lin-) HSPCs isolated from the BM of SD mice.
We transduced Lin-HSPCs with the different LVs at MOI 50. Transduced cells were plated in a methylcellulose-based medium for the colony forming cell (CFC) assay. The leftover was plated for differentiation in liquid cultures (LC). Fourteen days later, colonies were counted and LC were collected to perform VCN and β-Hex enzymatic activity. All LVs proficiently transduced Lin-HSPCs without evident We differentiated human induced pluripotent stem cell (iPSCs) -obtained by reprogramming of healthy donors (HD) fibroblasts -into NPCs and differentiated progeny using a protocol that generates a mixed populations of neurons, astrocytes, and oligodendrocytes at different stages of differentiation/maturation [46] . Seven days after plating, we exposed NPC-derived progeny to LV.hAB (MOI 2 and MOI 5; overnight incubation). Cultures were grown for additional 7 days in order to promote neuronal and glial differentiation and allow LV integration and transgene expression. Cultures were collected at day (d) 14 for molecular and biochemical analysis.
LV.hAB proficiently transduced hiPSC-derived neural progeny in a dose-dependent manner. The high VCN (range 20-30) obtained in LV-transduced cell populations using these relatively low MOIs reflects the presence of variable amount of intracellular non-integrated vector in transduced cells, which is expected since these cells do not actively proliferate in these culture conditions (≈10% of proliferating cells at d14 of differentiation) [46] . The average composition of NPC-derived cultures at d14 is: ≈ 15-20% neurons (TUJ1), Table 1 ). Overall, these data suggest that LV.hAB-mediated transduction and-Hex overexpression are well tolerated by iPSC-derived neural progeny and result in efficient production and secretion of functional HexA.
We used commercially available CD34+ HSPCs isolated from healthy donors (n=2; donor#1 and donor#2), which underwent one round of transduction using LV.hAB (MOI 100) according to described protocols [47, 48] . The VCN measured in LV-transduced HSPC progeny after 14 days of differentiation in liquid cultures (LC) was 0.66 (donor #1) and 0.42 (donor #2), in line with previous data [47] . LV-transduced cells displayed a detectable increase of β-Hex activity (≈2-fold and ≈1.6-fold the HD level for MUG-and MUGS-related activity, respectively; Fig.6F ), a physiological 10:1 MUG/MUGS ratio (8:1 in UT CD34+ cells), and a normal chromatographic profile ( Fig.6G-H) . In fact, LV.hAB-transduced cells display levels of HexB (≈52% of total Hex activity), HexI (≈11% of total Hex activity), and HexA (≈37% of total Hex activity) comparable to those found in CD34+ UT cells (HexB ≈52%; HexI≈11%; HexA≈ 37%; Suppl.
Journal Pre-proof J o u r n a l P r e -p r o o f Table 1 ). Overall these results provide proof of concept of the feasibility and efficacy of using bicistronic LVs to achieve safe β-Hex overexpression in human HSPCs.
Rescue of enzymatic activity in SD fibroblasts by bicistronic LV.hAB
We sought to obtain proof of concept of LV.hAB-mediated rescue of enzymatic activity and isoenzyme composition in fibroblasts (hFF) derived from a SD patient (healthy donor -HDfibroblasts were used as controls). SD fibroblasts were incubated overnight with LV.hAB (MOI 10 and MOI 20) and sub-cultured for 2 passages before being collected for molecular and biochemical analysis.
The VCN measured in LV.hAB-transduced SD fibroblasts ranged between 0.5 and 2.
LV-transduced SD fibroblasts displayed full rescue of β-Hex activity ( Importantly, LV.hAB-mediated enzymatic rescue led to clearance of GM2 storage, which is present in untreated SD fibroblasts ( Fig.7F ).
Collectively, these results indicate that the bicistronic LV.hAB drives the synthesis and secretion of functional β-Hex enzyme in SD fibroblasts, highlighting its biological efficacy in a patient-derived cell type.
DISCUSSION
Gene therapy (GT) is a promising approach to ensure a steady supply of β-Hex to CNS and other affected tissues potentially for the recipient's lifetime, with the capacity to comprehensively address GM2 gangliosidosis pathology. Hematopoietic stem cell gene therapy (HSC GT), in which autologous HSPCs are engineered with LVs to overexpress a functional enzyme, provides benefit in a similar LSD, metachromatic leukodystrophy [21, 22] , supporting the rationale for applying a similar approach to GM2 gangliosidosis.
Prospectively, coupling the benefit of HSC GT with the timely enzymatic supply to CNS tissues provided by LV-mediated intracerebral (IC) GT is expected to provide a synergistic effect [49] . The experimental work The peculiar biological features, coupled to scalable manufacture for clinical applications, make LVs safe and effective vehicles in the context of in vivo and ex vivo GT approaches for LSDs, as suggested by pre-clinical studies [48, 49] and results of recent Phase I/II clinical trials [21, 22] . Importantly, the large LV cargo capacity [36, 50] may overcome the issue of vector co-delivery or the need of developing small size chimeric proteins, facilitating the development of GT strategies for GM2 gangliosidosis. Based on these premises, we developed bicistronic LV constructs in which the murine and human genes coding for the-J o u r n a l P r e -p r o o f and -subunits are linked by a P2A self-cleaving peptide, which allows for stoichiometric and concordant expression of the two genes [51] . In order to ameliorate the stability of the transcript and improve enzyme expression, we took advantage of codon optimization. Indeed, recoding the transgene to optimize transcription and translation has already been demonstrated to improve LVs titers as well as protein production and the efficacy of therapies, i.e., for chronic granulomatous disease, haemophilia A and B, SCID, GLD and MLD [21, 48, 52, 53] .
Our results show safe and effective bicistronic LV-mediated transduction of murine SD NPCs and differentiated progeny, a cellular model that recapitulates the pattern of β-Hex expression and isoenzymatic composition and display consistent GM2 storage and lysosomal expansion, two main LSD pathological hallmarks [54] . All LVs proficiently transduced SD NPCs, resulting in multiple copies of integrated LV genome/cell (VCN). The comparable VCN measured in cells transduced with either bicistronic LVs (MOI 50) or co-delivered monocistronic LVs (MOI 50 +50) may reflect an early counter selection of the doubletransduced cells achieving an excessive vector load. The use of bicistronic LVs has the potential to decrease the LV dose needed for effective transduction, further improving the safety profile. All LV-transduced NPCs cells maintained normal proliferation and multipotency over time in vitro, confirming previous data showing safe LV-mediated gene transfer in NPCs derived from LSD murine models [40, 55] .
Our comprehensive molecular and biochemical analysis showed that bicistronic LVs outperform the co-delivered monocistronic LVs in achieving stoichiometric expression of the α-and β-subunits in SD NPCs and progeny. Indeed, while the co-delivery of monocistronic LVs -and even the single delivery of LV.mBwas sufficient to boost β-Hex activity, only transduction with bicistronic LVs resulted in close-tophysiological MUG-and MUGS-related activity and balanced HexA/HexB expression. Importantly, transduction with bicistronic LV.hAB resulted in supranormal levels of β-Hex activity and correct isoform expression in iPSC-derived human neurons/glial cells derived from healthy donors. We have previously shown that therapeutic LVs mediated enzymatic rescue of neurons and glial cells derived from MLD patients [56] and GLD NHP [35] . The formation of mature HexA and HexB transgenic proteins in LV.hABtransduced murine SD NPCs and progeny as well as in SD patient-derived fibroblasts suggests the biological efficacy of the bicistronic LV.hAB in SD pathology. In addition, these data support the advantage of this bicistronic construct (hexb-P2A-hexa) as compared to the one described previously (hexb-IRES-hexa), which led to an excess of ββ at the expenses of αβ formation in SD fibroblasts [37] . Based on these premises, we expect a similar safety and efficacy profile in SD patient-derived neural cells, which should be ultimately tested as they represent the target of prospective intracerebral GT approaches.
The production and secretion of (supra) physiological HexA from HSPCs and progeny is mandatory to exploit the potential of autologous HSC GT for the treatment of GM2 gangliosidosis. We leveraged on a LV GT platform that has been effectively applied to (over)express therapeutic transgenes (including lysosomal enzymes) in HSPCs, both in in pre-clinical studies [48, 57] and in the context of autologous ex vivo HSC GT Phase I/II clinical trials in patients with MLD [21, 22] , WAS [58, 59] , β-thalassemia [60] and MPS I (ClinicalTrials.gov Identifier: NCT03488394). Our results extend the applicability of this platform to bicistronic LVs expressing the α-and β-subunits of β-Hex enzyme, which showed a clear advantage as The therapeutic benefit expected by in vivo and/or ex vivo GT approaches for LSDs not only rely on the direct correction of endogenous CNS cells or pervasive replacement of tissue resident myeloid cells with HSPC-derived functional counterparts, but also on the release of part of functional enzyme by genetically modified cells for its uptake by neighbouring enzyme-deficient cells (metabolic cross-correction). The extent of secretion and reuptake varies among the different lysosomal enzymes and in different cells types [72, 73] .
Previous works reported cross-correction of SD fibroblasts [37] , but limited information is available for neural and hematopoietic cells [74] [75] [76] . We detected 10-20% of normal β-Hex activity in cross-corrected SD neurons/glia cultures exposed to supranormal enzymatic activity. This was sufficient to achieve a 30-60% reduction of GM2 and GA2 storage in these in vitro models, as evaluated using different assays.
Optimization of LV and transgene design may improve vector particle distribution and enhance enzyme bioavailability in the context of GT approaches [77, 78] . Tailored experiments testing β-Hex activity in the J o u r n a l P r e -p r o o f Serially subcultured NPCs (passages 5-10) were plated in growth medium (proliferating conditions) in 6well plates (30,000 cells/cm 2 ). Eight hours after plating cells were incubated overnight with LVs at MOI 50.
LV-containing medium was then removed, fresh medium added, and cells incubated for additional 4-6 days in order to obtain neurospheres that were further subcultured to establish stable LV-transduced NPC lines.
LV-transduced NPCs were analysed for their functional features before being used for the experiments.
Functional characterization of NPCs
Proliferation. Long-term proliferation of the bulk NPC cultures was assessed by generating growth curves, as previously described [81] . Briefly, we plated 2x10 5 viable cells in a 25 cm 2 flask (0 days in vitro-DIV) in growth medium. At each subculture passage (every 4-5 days) the total number of viable cells was counted and 2x10 5 cells were replated under the same conditions. This procedure was repeated for at least 5 subculture passages. The estimated total number of cells was calculated by multiplying the amplification rate (total number of cells obtained at a given subculture passage/2x10 5 ) for the total number of cells obtained at the previous passage. The total number of cells (in log10 scale) was plotted against the DIV. Data were interpolated using a linear regression model and best fitted the following equation: y = a + bx, where y is the estimated total number of cells (in log scale), x is the time (DIV), a is the intercept (constrain: 2x10 5 ), and b is the slope. The best-fit value, the standard error, and the 95% confidence intervals of the slope for each dataset were calculated. The slope values were then compared using one-way ANOVA followed by Dunnet's multiple comparison test. Statistical significance was accepted with P ≤ 0.05.
Clonogenic assay. Serially passaged neurospheres were dissociated and cells were plated in growth medium
(1,000 cells/cm 2 in 48-well plates). The number of newly formed neurospheres in each well was counted after 7 days. The ratio between the number of neurospheres obtained and the number of plated cells (x100) is indicated as clonal efficiency.
Multipotency. Cells were induced to differentiate by progressive removal of growth factors. Serially passaged NPCs were plated (40,000 cells/cm 2 ) onto an adhesive substrate (matrigel) in growth medium for two days. The resulting population (precursors) was either collected for molecular and biochemical analysis or further induced to lineage commitment and differentiation by exposure to FGF2-containing medium for 48h, followed by 5 days in a mitogen-free medium containing 2% FBS, to drive the differentiation into neurons and glia (differentiated cells). The percentage of neuronal and glial cells in differentiated cells was assessed by immunofluorescence analysis and quantification using lineage-specific markers.
Isolation and transduction of murine hematopoietic stem/progenitor cells (HSPCs)

J o u r n a l P r e -p r o o f
MethoCult, H4434; murine Methocult, StemCell 03434). After 14 days, colonies were scored and counted (CFC assay); ii) plated in RPMI medium (Corning 15040CVR), 10% FBS (Euroclone ECS0180L), 1% P/S (Lonza 17-602E), 1% l-glutamine (Lonza 17-605E), and cytokines (mSCF, 5 ng/ml; hFlt3L, 10 ng/ml; mIL3, 10 ng/ ml; TPO, 50 ng/ml; all from Peprotech), cultured for 14 days before being collected and analyzed for VCN, enzymatic activity and isoenzyme composition (liquid cultures, LC).
Human cells
Human cells were used according to the guidelines on human research issued by the San Raffaele Scientific [46] . All the cells used were mycoplasma-free (tested once every two weeks). Briefly, iPSC-derived NPCs were cultured in proliferating medium (NPCM; basal medium containing FGF2 and EGF), detached using Accutase and re-plated on Matrigel-coated dishes (20,000 cells/cm 2 ) in NPCM (d0). During the first 4 days after plating (d4) we gradually replaced NPCM with increasing amount of differentiation medium (basal medium supplemented with 10 ng/ml PDGF-AA, 10 ng/ml NT3, 10 ng/ml IGF-1, 5 ng/ml HGF, and 60 ng/ml T3) in order to favour neural lineage commitment and differentiation. From d4 to d13 medium was changed every other day. At d7, cultures were incubated overnight with LV.hAB (MOI 2 and MOI 5) supplemented with 8 mg/ml Polybrene (Sigma-Aldrich, St. Louis, MO). Then, LV-containing medium was removed, and fresh medium added for additional 7 days. Cells were analysed at d14 for VCN, morphology and cell type composition, enzymatic activity and isoenzyme composition. Cultures at ≈70% confluence were incubated with LV.hAB (MOI 10, MOI 20) overnight. LV-containing medium was then removed and fresh HFM added. Cells were collected 10 days after transduction and analysed for VCN, enzymatic activity, isoenzyme composition, and immunofluorescence.
Quantification of vector copy number (VCN)
Genomic DNA (gDNA) from human and murine cells was extracted from cellular pellets (Maxwell 16 Cell DNA purification kit, Promega), following the manufacturer instructions. gDNA was quantified by 260/280 nm optical density (OD) reading on the NanoDrop ND-1000 Spectrophotometer (Euroclone, Pero, Italy).
The number of vector copies integrated in the host genome (vector copy number, VCN) was quantified by quantitative droplet dd-PCR, using the custom primers and probes listed below. VCN were normalized to genomic DNA content, which was assessed using the murine SEMA3A or the human TELO gene. VCN analysis by ddPCR involved quantification of target and reference loci through the use of duplex target and reference assays. In QuantaSoftTMsoftware, copy number was determined by calculating the ratio of the target molecule concentration to the reference molecule concentration, times the ploidy of reference species.
Murine endogenous gene primers and probes:
Sema3A primers/HEX probe set 
Immunofluorescence (IF)
Double-labelling immunofluorescence was performed as previously described [39] . 
Image acquisition and quantification
Coverslips were visualized with a Nikon Eclipse E600 microscope and images were acquired at 20x or 40x magnification with Nikon DS Ri-2 camera, using NIS-Elements F imaging software (Nikon, Japan).
Immunoreactive cells were counted in at least 5 non-overlapping fields in each sample (>300 cells/sample) and expressed as a percentage on the total nuclei. Data are the mean ± SEM of two-three coverslips in three independent experiments. Images were analysed by the ImageJ software to quantify GM2 and LAMP1 signal intensity corresponding to immunopositive areas (expressed in pixels). UT samples were used for setting the threshold. The area was normalized on the number of nuclei in the same field. The merged images were obtained using the Volocity Software (v5.2.1; PerkinElmer-Improvision, Lexington, MA). Images were imported into Adobe Photoshop CS4 and adjusted for brightness and contrast.
Confocal images were acquired at 63x magnification with a Leica TCS SP8 confocal microscope and analysed with LasX software.
Real time RT-PCR
Total RNA was extracted from cells by RNeasy mini Kit (Qiagen, Hilden, Germany), following the manufacturer's instructions. Reverse transcription was carried out using 1 μg of total RNA and the Quantitect Human codon-optimized Hexosaminidase  subunit Custom
-Hexosaminidase activity and isoenzyme composition
Enzymatic activity and isoenzyme composition was determined in cell extracts as previously described [39, 43, 82, 83] and briefly summarized here. Fractions (0.5 mL) were collected and assayed for the Hex activity.
Cross-correction of SD NPCs and progeny
Donor cells (WT UT or LV.mAB-transduced SD NPCs) were plated on an adhesive substrate (matrigel) in medium containing FGF2 (20,000 cell/cm 2 ) (d0). After 48h (d2), the supernatant (Sup) was removed and substituted with fresh medium without mitogens containing 2% FBS. This medium change was repeated at d4 and d6. The Sup collected at d4 and d6 was centrifuged to remove debris and used to treat acceptor cells (SD UT) that had been plated under the same differentiating conditions. After a 24h-washout with fresh medium, we collected acceptor cells and their Sup. Enzymatic activity was measured in the Sup and pellet of donor and acceptor cells, as described above.
Sphingolipid analysis
J o u r n a l P r e -p r o o f SD NPCs were plated on an adhesive substrate (matrigel) in medium containing FGF2 (20,000 cell/cm 2 )
supplemented with 12 nM of [1-3 H]-sphingosine (specific radioactivity 1.06 Ci/ mmol). After 48 hours we removed the medium and incubated cells with either fresh medium or with the Supernatant (SUP) collected from donor cells, according to the cross-correction protocol described above. At the end of the experiment, cell lipids were extracted using the solvent system chloroform:methanol:water, 2:1:0.1, by volume. Total lipids extracts were subjected to phase separation according to Folch method with some modifications, as previously described [84, 85] . Finally, organic phases were subjected to alkaline methanolysis to remove glycerophospholipids [85] . Lipids contained in the organic and aqueous phases were separate by HPTLC using the solvent system chloroform:methanol:water 110:40:6 (v:v:v) and chloroform:methanol:CaCl 2 0.2%, 50: 42:11 (v: v: v), respectively. Radioactive lipids were detected by digital autoradiography performed with a Beta-Imager T Racer system (BioSpace lab) and quantified using M3 vision software. Identification of lipids after separation was assessed by co-migration with authentic radioactive lipid standards.
Western Blotting
Protein samples were extracted as described above. After boiling for 5 min in loading buffer, samples Pearson r = 0.868, p = 0.0248 for MUGS).
Fig. S3 Enzymatic activity in human iPSC-de rived NPCs
Correlation of enzymatic activity (MUG and MUGS, expressed as nmol/mg*hour) measured in the pellet (intra-cellular, on the x axis) and in the supernatant (extra-cellular, on the y axis) of untransduced (UT) and
LV.hAB-transduced human iPSC-derived NPCs (Multiplicity Of Infection: MOI2 and MOI5). n=3; Pearson r = 1, p = 0.0035, ** for MUG; Pearson r = 0.936, p = 0.0723 for MUGS). 
